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Background: Brugada syndrome is a disease 
characterized by a specific electrocardiographic pattern 
and an increased risk of sudden cardiac death. We 
present this case with the updated literature to emphasise 
the need to consider the diagnosis of Brugada syndrome 
in patients admitted to the emergency ward with sudden 
cardiac arrest. 
Case Report: A 16-year-old female patient was 
admitted to the emergency ward with complaints of 
weakness and abdominal pain, and she had four cardiac 
arrests during her evaluation period. She was referred 
to our clinic for permanent pacemaker implantation. 
She was on a temporary pace maker after having had 
C-reactive protein. Her physical exam was normal 
except for bilaterally decreased lung sounds. Lung x-ray 
and computed tomography, which were performed by 
another institution, revealed minimal pleural effusion 
and nothing else of significance. Blood and peritoneal 
fluid samples were sterile. Echocardiographic exam 
and cardiac enzymes were also in the normal ranges. 
Electrocardiographic showed incomplete right branch 
block in leads V1 and V2. An ajmaline test revealed 
specific electrocardiographic findings of the type I 
Brugada pattern. We proposed implanting an implantable 
cardioverter defibrillator to the patient as there were 
positive findings on the ajmaline test as well as a history 
of sudden cardiac arrest. After this treatment proposal, 
the patient’s family admitted that she had taken a high 
dose of verapamil and thus, the encountered bradycardia 
was associated with verapamil overuse. The ajmaline 
test was repeated as it was contemplated that the 
previous positive ajmaline test had been associated with 
verapamil overuse. Implantable cardioverter defibrillator 
implantation was proposed again as there was a history 
of sudden cardiac arrest; however, the family did not 
consent to implantable cardioverter defibrillator, and the 
patient was discharged and followed up. 
Conclusion: Brugada syndrome should be considered 
for patients who are admitted to the emergency ward with 
sudden cardiac arrest though surface electrocardiographic 
is normal. If there is a suspicion of Brugada syndrome, 
repeated electrocardiographic should be performed 
on	 different	 occasions.	 Diagnosis	 can	 be	 clarified	 by	
upper costal electrocardiographic or by administering 
Na channel blockers during electrocardiographic 
performance.
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 Brugada syndrome (BrS) is a hereditary arrhythmia characterized 
by an electrocardiographic (ECG) pattern and an increased risk 
of sudden cardiac death without structural abnormalities. The 
syndrome predominantly affects young adult men, and the first 
clinical symptoms occur at the age of approximately 40 years 
(1). We aim to share the case of a 16-year-old patient who was 
admitted after a resuscitated cardiac arrest and was diagnosed 
with BrS. It was learned that she had attempted suicide by 
verapamil overdose before the cardiac arrest. 
CASE PRESENTATION
A 16-year-old girl was admitted to another centre with dizziness, 
nausea and abdominal pain. Abdominal ultrasonography 
revealed free fluid in the abdomen. The patient underwent 
laparoscopy with the suspected diagnosis of ovarian torsion, and 
diagnostic fluid was drained. She had four episodes of cardiac 
arrest (asystole) following severe bradycardia during and after 
this procedure, and a temporary pacemaker was inserted. The 
patient was referred to our clinic under emergency conditions for 
permanent pacemaker insertion. The physical examination in our 
clinic was normal, except for decreased bilateral breath sounds 
in the lower zones. When the patient and family were insistently 
questioned regarding intoxication, no information was obtained 
on this subject. The chest radiogram revealed bilateral minimal 
pleural effusion and the thoracic tomography demonstrated 
minimal pleural effusion in both hemithoraces. The blood levels 
of the acute-phase reactants were normal, blood cultures were 
negative and rheumatologic investigations were normal. The 
effusion disappeared with antibiotic treatment for pneumonia 
during follow-up. The echocardiographic examination, which 
was performed to exclude myocarditis due to the history of 
unexplained sudden cardiac arrest, and the cardiac enzymes 
were normal. The 24-hour Holter monitorization revealed rare 
premature ventricular contraction. ECG examination showed 
an incomplete right bundle branch block (RBBB)-like pattern 
on V1-V2 (Figure 1). No pathology was detected on selective 
coronary angiography, which was performed to exclude 
coronary artery abnormalities. Third costal position ECG, 
which has a higher sensitivity in unmasking type I BrS ECG 
was used (2). Electrocardiogram showed typical BrS findings 
in the third costal position during the ajmaline test; however, 
simultaneous ECG in the fourth costal position was completely 
normal (Figure 2a, b). Because of the history of cardiac 
arrest and the positive ajmaline test, implantable cardioverter 
defibrillator	 (ICD)	 implantation	 was	 recommended	 to	 the	
patient. The bradycardia and cardiac arrest were attributed to 
verapamil; however, the positivity of the ajmaline test could not 
be explained by this, and the test was repeated after the patient 
had recovered from bradycardia, producing another positive 
result.	ICD	insertion	was	recommended	for	the	development	of	
cardiac arrest (asystole) with bradycardia in our patient. When 
we	 insisted	on	 ICD	 insertion,	 it	was	 revealed	 that	 the	patient	
had attempted suicide by taking a high dose of verapamil. The 
patient's cardiac arrest was attributed to verapamil intoxication. 
BrS was diagnosed incidentally in this patient. There was no 
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FIG. 1. The baseline electrocardiographic examination showed an 
incomplete right bundle branch block in V1-V2.
FIG. 2. a, b. Electrocardiography showed typical Brugada syndrome 
findings in the third costal position during the ajmaline test, however 
simultaneus electrocardiographic in the fourth costal position was 
completely normal. 
history of sudden cardiac death and no evidence of BrS on ECGs 
and genetic screening tests performed on the patient’s family. 
ICD	 insertion	 was	 not	 performed	 because	 of	 asymptomatic	
BrS; the patient was discharged, and follow-up was continued. 
Using	the	DNA	sample	from	the	patient’s	peripheral	blood,	the	
presence	 of	 c.87A>G	 (p.A29A)	 (heterozygous),	 c.3183A>G	
(p.E1061E)	 (heterozygous)	 and	 c.5457C>T	 (p.D1819D)	
(heterozygous)	was	 identified	 in	 the	DNA	 sequence	 analysis	
of the SCN5A gene. The patient and her family were provided 
with information about this current work, and informed consent 
forms were signed.
DISCUSSION
BrS is a disease characterized by sudden cardiac death, 
typically occurring during sleep in relatively young 
individuals. It may be detected in every age group from early 
infancy to the elderly, occurring most frequently in the fourth 
decade of life and the male gender. The primary mechanism 
of BrS is mutations in the SCN5A gene, which are responsible 
for regulation of the alpha subunit of sodium channels in the 
cell membrane of cardiac muscle (3). BrS is characterized 
by	the	RBBB	pattern	and	coved-type	ST	elevation	>2	mm	in	
V1-V3 derivations on ECG (1). This ECG pattern is called 
type I. In some cases, the RBBB pattern and an ST elevation 
>2	mm	with	the	saddle-back	type	instead	of	the	coved	type	
were detected, and this ECG pattern is called type II. If it 
is either a saddle-back or a coved-type ST elevation and <2 
mm, it is called type III. Among these ECG patterns, type I 
is diagnostic, whereas types II and III are not. Additionally, 
sometimes BrS is hidden with very mild ECG changes. If there 
are suspicious clinical conditions and syncope with suspected 
ECGs or unexplained sudden deaths in family members, 
special tests should be performed to investigate the presence 
of BrS. These tests are performed by administering sodium 
channel blockers to patients, such as flecainide, ajmaline, 
procainamide, propafenone and disopyramide, while 
recording the changes in the ECG. If the ECG changes show 
an alteration from types II or III to type I, then BrS should be 
considered. Since dangerous arrhythmias may develop during 
these tests, the patient’s rhythm should be monitored closely. 
For our patient, the diagnosis was confirmed by the positive 
ajmaline test. The mean age at which symptoms first appear in 
affected individuals is the third to fourth decade. Among the 
initial reports however, one described symptomatic twins who 
were 1 year of age, and more recent reports describe families 
with symptomatic children (4). It was important in the current 
case that the patient was a 16-year-old girl, and there was 
no BrS diagnosis and/or sudden death at a young age in the 
family history. The reason for the early age of the diagnosis 
in this patient was her admission with severe bradycardia 
and cardiac arrest due to verapamil intoxication. In most 
reported cases, a large number of sudden cardiac deaths at a 
young age are reported in the family history. The basal ECGs 
from the screening of the family of the present case and the 
ajmaline test administered to her parents were evaluated to be 
negative. The early detection of the initial case is important 
for diagnosing further secondary cases in the family. 
The	most	common	mutations	associated	with	BrS	are	GPD1L	
(prevalence of 11%-12%) and SCN5A (prevalence of 18%-
30%) mutations (5). To date, approximately 300 mutations 
in the SCN5A gene have been described in association with 
BrS. Six other genes (CACNA1C, CACNB2, SCN1B, KCNQ3, 
SCN3B, and HCN4) have been associated with BrS, but the 
prevalence of variants in these genes is yet unknown (6). Using 
the	DNA	sample	from	the	peripheral	blood	of	the	patient,	the	
presence	 of	 c.87A>G	 (p.A29A)	 (heterozygous),	 c.3183A>G	
(p.E1061E)	 (heterozygous)	 and	 c.5457C>T	 (p.D1819D)	
(heterozygous)	were	identified	in	the	DNA	sequence	analysis	
of the SCN5A gene. The mutation screening test program was 
used	to	investigate	the	c.5457C>T	nucleotide	change;	however,	
no association with a disease was established. Additionally, it 
can be said that there was no change at the level of amino acids 
when	 considered	 for	 the	 proteins	 (p.D1819D)	 (i.e.,	 this	 is	 a	
silent type of mutation), and this mutation will not cause any 
specific disease due to not create a difference in the amino acid 
chain.	A	previous	 study	 reported	 that	 the	 c.5457C>T	change	
was	common	in	the	patients	with	“short	QT	interval”	syndrome;	
however, this was not reported as directly associated with the 
disease	(7).	We	believe	that	the	role	of	such	silent	mutations	in	
BrS will be much clearer as the number of the cases increase. 
In risk stratification and corroboration diagnosis, 
electrophysiological studies may be useful. According to recent 
reports, sudden death from ventricular fibrillation (VF) is the first 
symptom with BrS patients. The episodes of syncope are caused 
by rapid polymorphic ventricular tachycardia. Approximately 
80% of patients with documented VF have a history of syncope 
(8). Cardiac arrest in patients with BrS generally occurs during 
sleep or rest (9). Neither ventricular tachycardia (VT) nor VF 
was induced by EPS in our patient. The single proven effective 
method	of	 treatment	 for	BrS	 is	 the	 insertion	of	 an	 ICD	 (10).	
Pharmacological treatment approaches have been developed for 
patients	with	an	ICD	inserted	and	who	are	exposed	to	multiple	
shocks	due	to	arrhythmia	attacks	(10).	Quinidine	is	suggested	
as	an	alternative	to	ICD	for	children	who	have	had	ICD	and	who	
are exposed to many shocks and ventricular arrhythmia storm 
in particular (10). It is very difficult, especially for paediatric 
patients,	 to	 be	 convinced	 about	 ICD	 insertion	 and	 to	 adapt	
themselves	to	this	situation.	ICD	insertion	is	not	recommended	
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in asymptomatic BrS patients with a drug-induced type I ECG 
(10).	ICD	insertion	was	not	performed	because	of	asymptomatic	
BrS in this case, and the patient continued to be followed up.
BrS can be easily diagnosed by simple ECG changes 
and medical history; however, it is frequently missed or 
misdiagnosed in daily practice. BrS should be considered in 
the differential diagnosis of patients admitted to the emergency 
service with ST elevation in V1-V3 derivations on ECG, VT, 
syncope or sudden cardiac arrest. Although there are several 
technologically advanced diagnostic tools, they are not 
available in the emergency clinic; however, a basic diagnostic 
tool like ECG is easily accessible. Given the possibility of 
sudden cardiac death from BrS, emergency room physicians 
must	be	familiar	with	BrS.	Our	case	also	demonstrates	once	
again that risk stratification in the appropriate management of 
BrS patients is of paramount importance in order to prevent 
overtreatment with high-risk, life-long cardiac devices. 
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